Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study.
Testa S, Palareti G, Legnani C, Dellanoce C, Cini M, Paoletti O, Ciampa A, Antonucci E, Poli D, Morandini R, Tala M, Chiarugi P, Santoro RC, Iannone AM, De Candia E, Pignatelli P, Faioni EM, Chistolini A, Esteban MDP, Marietta M, Tripodi A, Tosetto A. Testa S, et al. Among authors: dellanoce c. Blood Adv. 2024 Apr 23;8(8):1846-1856. doi: 10.1182/bloodadvances.2023012408. Blood Adv. 2024. PMID: 38394387 Free PMC article.
Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics.
Testa S, Tripodi A, Legnani C, Pengo V, Abbate R, Dellanoce C, Carraro P, Salomone L, Paniccia R, Paoletti O, Poli D, Palareti G; START-Laboratory Register. Testa S, et al. Among authors: dellanoce c. Thromb Res. 2016 Jan;137:178-183. doi: 10.1016/j.thromres.2015.12.001. Epub 2015 Dec 2. Thromb Res. 2016. PMID: 26672898 Clinical Trial.
Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants.
Testa S, Legnani C, Antonucci E, Paoletti O, Dellanoce C, Cosmi B, Pengo V, Poli D, Morandini R, Testa R, Tripodi A, Palareti G; Coordinator of START2-Register. Testa S, et al. Among authors: dellanoce c. J Thromb Haemost. 2019 Jul;17(7):1064-1072. doi: 10.1111/jth.14457. Epub 2019 May 26. J Thromb Haemost. 2019. PMID: 31013383 Free PMC article.
Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience.
Testa S, Prandoni P, Paoletti O, Morandini R, Tala M, Dellanoce C, Giorgi-Pierfranceschi M, Betti M, Danzi GB, Pan A, Palareti G. Testa S, et al. Among authors: dellanoce c. J Thromb Haemost. 2020 Jun;18(6):1320-1323. doi: 10.1111/jth.14871. Epub 2020 May 6. J Thromb Haemost. 2020. PMID: 32329231 Free PMC article.
Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register.
Cini M, Legnani C, Cosmi B, Testa S, Dellanoce C, Paoletti O, Marcucci R, Poli D, Paniccia R, Pengo V, Tripodi A, Palareti G; START-Laboratory Register. Cini M, et al. Among authors: dellanoce c. Int J Lab Hematol. 2018 Apr;40(2):229-236. doi: 10.1111/ijlh.12772. Epub 2018 Jan 3. Int J Lab Hematol. 2018. PMID: 29314632
46 results